🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share comparison images, administration instructions and assertions of next-day British shipping. Sellers market the drug there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Voice Worries

However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to individuals administering products of unknown origin.

Several experts said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Service Response and Content Elimination

According to TikTok, the service has removed problematic content and prohibited related keywords and search suggestions. The company stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Operations

Research also discovered groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After minutes of joining one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.

Product Details and Pricing

Within these communities, posts show black plastic packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram stated it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the research behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to possibly significant health risks”.